Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.

Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis. Int J Clin Exp Med (2015) 0.78

Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38

Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell (2011) 3.88

Proteomic applications for the early detection of cancer. Nat Rev Cancer (2003) 3.61

Clinical proteomics: written in blood. Nature (2003) 2.81

Hepatocellular carcinoma. J Hepatol (2000) 2.77

Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg (2006) 2.52

The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer (2005) 2.05

Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med (2007) 1.75

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology (2005) 1.55

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology (2005) 1.54

Microwave ablation of hepatocellular carcinoma. Oncology (2007) 1.34

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One (2012) 1.24

Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun (1998) 1.22

Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer (2006) 1.18

Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg (2007) 1.16

Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology (2004) 1.09

Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res (2008) 1.05

A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers (2001) 0.99

Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut (2011) 0.98

Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics (2006) 0.95

Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol (2007) 0.95

Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma. J Cell Biochem (2008) 0.93

Monitoring RF ablation. Eur Radiol (2004) 0.93

Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer (2006) 0.92

Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology (2004) 0.91

Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery. Proteomics (2006) 0.90

Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med (2009) 0.89

Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. J Cell Biochem (2006) 0.87

Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia (2011) 0.85

Serum protein-expression profiling using the ProteinChip biomarker system. Methods Mol Biol (2004) 0.85

Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat (2006) 0.82

Ultrasound-guided microwave coagulation assists anatomical hepatic resection. Surg Today (2011) 0.82

Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology (2004) 0.81

Image-guided microwave ablation of hepatic tumours: preliminary experience. Radiol Med (2011) 0.80

Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol (2007) 0.79

Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. J Gastroenterol Hepatol (2007) 0.79

Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS. Pancreatology (2012) 0.77